Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success.
- DOI
- 10.1136/bmjresp-2026-004232
- Published
- 2026 Jul 31
- Container
- BMJ open respiratory research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjresp-2026-004232,
title = {Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success.},
author = {Burton R and Puthoor M and Fyles F and Lewis L and Joplin H and Burhan H},
year = {2026},
journal = {BMJ open respiratory research},
doi = {10.1136/bmjresp-2026-004232},
url = {https://doi.org/10.1136/bmjresp-2026-004232}
}RIS
TY - JOUR TI - Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success. AU - Burton R AU - Puthoor M AU - Fyles F AU - Lewis L AU - Joplin H AU - Burhan H PY - 2026 JO - BMJ open respiratory research DO - 10.1136/bmjresp-2026-004232 UR - https://doi.org/10.1136/bmjresp-2026-004232 ER -
APA
R, B., M, P., F, F., L, L., H, J., & H, B. (2026). Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success.. BMJ open respiratory research. https://doi.org/10.1136/bmjresp-2026-004232
Source records
- pubmed · retrieved 2026-09-25T10:50:37.061Z